Literature DB >> 10919146

[Hashimoto encephalopathy: steroid-sensitive encephalopathy in Hashimoto thyroiditis].

M Hartmann1, B Schaner, K Scheglmann, A Bücking, R Pfister.   

Abstract

Hashimoto's encephalopathy is a steroid-responsive, relapsing or progressive encephalopathy associated with Hashimoto's thyroiditis. Characteristic clinical features are confusion, seizures, alteration in conscious level, stroke-like episodes, myoclonus, and tremulousness. High CSF protein levels without pleocytosis and a diffusely abnormal EEG are typical findings. Brain CT and MRI and cerebral angiogram are usually normal. We present two case reports of Hashimoto's encephalopathy in 55- and 77-year-old patients who both responded well to steroid therapy, and review the literature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919146     DOI: 10.1007/s001150050613

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  5 in total

Review 1.  Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy).

Authors:  Gianluca Tamagno; Giovanni Federspil; Giovanni Murialdo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Hashimoto encephalopathy: a do-not-miss in the differential diagnosis of dementia.

Authors:  Claire J Creutzfeldt; Roman L Haberl
Journal:  J Neurol       Date:  2005-06-13       Impact factor: 4.849

3.  [Organic schizophreniform disorder with pre-existing autoimmune thyroiditis].

Authors:  E Gruber; C Algermissen; H Ebel
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

4.  [Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].

Authors:  C Laske; T Leyhe; G Buchkremer; H Wormstall
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

5.  Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis.

Authors:  M Piga; A Serra; L Deiana; G L Loi; L Satta; M Di Liberto; S Mariotti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.